Text Size

Temporal Pattern of Circulating DNA for Patients Receiving Irradiation

This study has been terminated.
(Funding for project was withdrawn)
Sponsor:
Information provided by:
University of Rochester
ClinicalTrials.gov Identifier:
NCT01099020
First received: April 2, 2010
Last updated: August 2, 2011
Last verified: August 2011
History of Changes
  Purpose

The purpose of the research study is to test a measurement tool that will determine the radiation dose people receive when they have been accidentally exposed to radiation. This test will be done using a small amount of blood and known dose of radiation.


Condition
Radiation

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Temporal Pattern of Circulating DNA for Patients Receiving Total Body Irradiation

Further study details as provided by University of Rochester:

Estimated Enrollment: 30
Study Start Date: April 2010
Estimated Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients receiving large volume of radiation for the treatment of their cancer

Criteria

Inclusion Criteria:

  • Patient must be scheduled to undergo Total Body Irradiation (TBI) as part of a conditioning regime for a Bone Marrow Transplant. OR, Be scheduled to undergo Radiation Therapy treatment for a malignancy or other disease and have a radiation treatment field that contains at least 2 liters of tissue receiving at least 2 Gy radiation dose over the first 5 days of treatment.
  • Patient must be willing to have blood draws as defined below.
  • Patient must provide study-specific informed consent prior to study entry.
  • Hemoglobin≥8.
  • Age ≥ 18, but not older than age 60.

Exclusion Criteria:

  • Patients not meeting the above inclusion criteria.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01099020

Locations
United States, New York
University of Rochester
Rochester, New York, United States, 14642
Sponsors and Collaborators
University of Rochester
  More Information

No publications provided

Responsible Party: Michael Milano, MD,PhD, University of Rochester
ClinicalTrials.gov Identifier: NCT01099020     History of Changes
Other Study ID Numbers: ULAB10008
Study First Received: April 2, 2010
Last Updated: August 2, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by University of Rochester:
Subjects receiving large volumes of Radiation

ClinicalTrials.gov processed this record on May 23, 2013